| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Innovex International (NYSE:INVX) sees Q3 sales of $230.000 million-$240.000 million vs $217.000 million analyst estimate.
Innovex International (NYSE:INVX) reported quarterly earnings of $0.22 per share which missed the analyst consensus estimate of...
Piper Sandler analyst Derek Podhaizer initiates coverage on Innovex International (NYSE:INVX) with a Overweight rating and a...
Innovex International, Inc. (NYSE:INVX) (the "Company" or "Innovex") is pleased to announce that it has complet...
Barclays analyst Eddie Kim maintains Innovex International (NYSE:INVX) with a Underweight and lowers the price target from $...
Innovex International (NYSE:INVX) sees Q2 sales of $225.000 million-$235.000 million.
Innovex International (NYSE:INVX) reported quarterly earnings of $0.21 per share which missed the analyst consensus estimate of...